chrX-139530783-A-T
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BS2BA1
This summary comes from the ClinGen Evidence Repository: NM_000133.3:c.19A>T variant results in a missense change in the signal peptide. This variant is reported at a frequency of 0.001643 (152/92537 alleles with 57 hemizygotes) in the non-Finnish European population in gnomAD v2.1.1, meeting the BA1 cut-off of >= 0.0000556. At least 2 individuals with the variant and normal FIX levels from the literature and internal laboratory data are reported (PMID:29296726) meeting the BS2 criterion. In summary, the variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1, BS2. LINK:https://erepo.genome.network/evrepo/ui/classification/CA10529708/MONDO:0010604/080
Frequency
Consequence
NM_000133.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
F9 | NM_000133.4 | c.19A>T | p.Ile7Phe | missense_variant | 1/8 | ENST00000218099.7 | NP_000124.1 | |
F9 | NM_001313913.2 | c.19A>T | p.Ile7Phe | missense_variant | 1/7 | NP_001300842.1 | ||
F9 | XM_005262397.5 | c.19A>T | p.Ile7Phe | missense_variant | 1/7 | XP_005262454.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
F9 | ENST00000218099.7 | c.19A>T | p.Ile7Phe | missense_variant | 1/8 | 1 | NM_000133.4 | ENSP00000218099 | P1 | |
F9 | ENST00000394090.2 | c.19A>T | p.Ile7Phe | missense_variant | 1/7 | 1 | ENSP00000377650 | |||
F9 | ENST00000479617.2 | n.26A>T | non_coding_transcript_exon_variant | 1/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000889 AC: 100AN: 112507Hom.: 0 Cov.: 23 AF XY: 0.000808 AC XY: 28AN XY: 34659
GnomAD3 exomes AF: 0.000918 AC: 168AN: 183102Hom.: 0 AF XY: 0.000842 AC XY: 57AN XY: 67692
GnomAD4 exome AF: 0.00131 AC: 1438AN: 1097226Hom.: 2 Cov.: 29 AF XY: 0.00127 AC XY: 461AN XY: 362702
GnomAD4 genome AF: 0.000888 AC: 100AN: 112563Hom.: 0 Cov.: 23 AF XY: 0.000806 AC XY: 28AN XY: 34725
ClinVar
Submissions by phenotype
Hereditary factor IX deficiency disease Uncertain:1Benign:4
Uncertain significance, no assertion criteria provided | clinical testing | ISTH-SSC Genomics in Thrombosis and Hemostasis, KU Leuven, Center for Molecular and Vascular Biology | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Benign, reviewed by expert panel | curation | ClinGen Coagulation Factor Deficiency Variant Curation Expert Panel, Clingen | Feb 09, 2024 | NM_000133.3:c.19A>T variant results in a missense change in the signal peptide. This variant is reported at a frequency of 0.001643 (152/92537 alleles with 57 hemizygotes) in the non-Finnish European population in gnomAD v2.1.1, meeting the BA1 cut-off of >= 0.0000556. At least 2 individuals with the variant and normal FIX levels from the literature and internal laboratory data are reported (PMID: 29296726) meeting the BS2 criterion. In summary, the variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1, BS2. - |
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Jan 08, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
F9-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 21, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Hereditary factor IX deficiency disease;C2749016:Thrombophilia, X-linked, due to factor 9 defect Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2023 | F9: BS1, BS2 - |
FACTOR IX POLYMORPHISM Benign:1
Benign, no assertion criteria provided | literature only | OMIM | Sep 01, 1989 | - - |
Hereditary factor IX deficiency disease;C2749016:Thrombophilia, X-linked, due to factor 9 defect;C5393318:Warfarin sensitivity, X-linked Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 15, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at